Skip to main content Skip to office menu Skip to footer
Minnesota Legislature

Office of the Revisor of Statutes

SF 1883

as introduced - 91st Legislature (2019 - 2020) Posted on 02/28/2019 03:16pm

KEY: stricken = removed, old language.
underscored = added, new language.

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 1.21 1.22 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 2.18 2.19 2.20 2.21 2.22 2.23 2.24
2.25 2.26 2.27

A bill for an act
relating to health; establishing a pharmacogenomics task force; requiring a report;
appropriating money; proposing coding for new law in Minnesota Statutes, chapter
144.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

new text begin [144.1478] PHARMACOGENOMICS (PGX) TASK FORCE.
new text end

new text begin Subdivision 1. new text end

new text begin Establishment. new text end

new text begin A pharmacogenomics (PGx) task force is established to
develop a process for making pharmacogenomics available statewide. For purposes of this
section, "pharmacogenomics" means the study of how an individual's genetic makeup, or
genotype, affects the body's response to prescription drugs. There is a growing body of
knowledge on using pharmacogenomics as a tool to improve the cost-effectiveness of
medication use and to use genomics to improve the risk-benefit profile of new and existing
drugs. Pharmacogenomics will increase the effective delivery of personalized health care.
new text end

new text begin Subd. 2. new text end

new text begin Duties. new text end

new text begin The task force shall:
new text end

new text begin (1) determine protocols needed to make PGx available statewide;
new text end

new text begin (2) determine what educational tools are needed for use by the health care workforce to
improve care and reduce adverse reactions from medications;
new text end

new text begin (3) convene providers, patients, payers, and ethical, legal, and social implications experts
to identify and develop protocols to overcome barriers to PGx implementation;
new text end

new text begin (4) consider the needs and perspectives of diverse and underrepresented communities;
new text end

new text begin (5) develop a statewide implementation plan for diffusion of PGx services and develop
the data required for informed decision-making; and
new text end

new text begin (6) establish, review, and report on guidelines and criteria which the task force considers
essential to advancing PGx in the state.
new text end

new text begin Subd. 3. new text end

new text begin Task force members. new text end

new text begin (a) The University of Minnesota and Mayo Clinic shall
select no more than 20 members that reflect a statewide geographical representation and
representation from diverse groups within the state. The University of Minnesota and Mayo
Clinic shall select members with professional expertise in PGx, patient representatives
interested in PGx, and interested parties who are able to provide technical information and
advice on PGx. Section 15.059, subdivision 6, shall govern the terms, expenses, and removal
of members.
new text end

new text begin (b) The member from the University of Minnesota or Mayo Clinic shall chair the first
meeting of the task force which must be convened by September 1, 2019. At the first meeting,
the task force shall elect a chair from its membership. The Department of Health shall
provide technical and administrative support services, including meeting space, as required
by the task force.
new text end

new text begin Subd. 4. new text end

new text begin Report required. new text end

new text begin The task force shall report annually to the chairs and ranking
minority members of the legislative committees with jurisdiction over health and data
privacy on the activities of the task force that have occurred during the previous year. The
first report shall be issued on January 15, 2020. At a minimum, the annual report must
include:
new text end

new text begin (1) a description of the task force's goals for the previous year and for the coming year;
new text end

new text begin (2) a description of the outcomes the task force achieved; and
new text end

new text begin (3) any legislative recommendations the task force has including a description of specific
legislation needed to implement the recommendations.
new text end

new text begin Subd. 5. new text end

new text begin Expiration. new text end

new text begin The task force expires September 1, 2024.
new text end

Sec. 2. new text beginAPPROPRIATION.
new text end

new text begin $....... in fiscal year 2020 and $....... in fiscal year 2021 are appropriated from the general
fund to the commissioner of health for the purposes of the task force under section 1.
new text end